Articles by tag "100-26"

1. OPEN ACCESS: Ramachandran, Anassuya et al. (2021) Pathogenic ACVR1(R206H) activation by Activin A‐induced receptor clustering and autophosphorylation. EMBO J.
2. OPEN ACCESS: Pandey, Kirti et al. (2023) A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Front Oncol.
3. Dual-enzyme activated theranostic nanoparticles for image-guided glioblastoma therapy
4. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
5. High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in Glioblastoma
6. Sulforaphane protects developing neural networks from VPA-induced synaptic alterations
7. Sustainable Alternatives to Fetal Bovine Serum: Evaluating the Role of Plant and Insect Protein Isolates in Serum-Free Media for Bovine Satellite Cell Proliferation in Cultivated Meat Production
8. Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma
9. Reduced EZH1/2 expression in imipridone-treated cells correlates with synergy following combinations with EZH1/2 or HDAC inhibitors in diffuse glioma and other tumors
10. Multi-omics landscape of alternative splicing in diffuse midline glioma reveals immune- and neural-driven subtypes with implications for spliceosome-targeted therapy